Black Diamond Therapeutics, Inc. is a precision oncology medicine company. The Company’s technology platform, Mutation-Allostery-Pharmacology (MAP) platform is designed to allow it to analyze population-level genetic sequencing data to identify oncog... Read more
MarketWatch
CNBC
SeekingAlpha
SeekingAlpha
Access detailed stock analysis from LSEG including analyst price target estimates.